We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Organon India has established a co-marketing arrangement with GlaxoSmithKline
Pharmaceuticals India for two of its oral contraceptive pills -- Femilon
and Cerazette.
The pharmaceutical industry could grow in the near future as a company from
the Republic of San Marino is inquiring about the possibility of setting up
shop in Malta.
Venus Remedies and Themis Medicare have entered into a marketing tie-up in which
the latter would launch formulations developed by Venus under its own brand
name.
In recent years, the Grand Island plant of Fujisawa Healthcare Inc. was the
only U.S. manufacturing site and one of three distribution centers for its Japanese
owner.
Dainihon Jochugiku (Kincho)
and Sumitomo Pharmaceuticals jointly announced that they have reached a basic
agreement on the transfer of Sumitomo Pharmaceuticals Healthcare (SPH) to Kincho.
Representatives of the governments of Turkey and Israel have signed
a bilateral industrial R&D agreement, covering hi-tech areas including biotechnology.
Drug industry groups in Brazil have urged national regulator Anvisa
to implement effective drug regulation, despite government pressure to ensure
the provision of so-called similar medicines at the lowest possible cost.